Search results for "disability"

showing 10 items of 989 documents

Assessment of functional outcomes in patients with head and neck cancer according to the International Classification of Functioning, Disability and …

2013

Background The International Classification of Functioning, Disability and Health Core Set for Head and Neck Cancer (ICF-HNC) covers the typical spectrum of problems in functioning in head and neck cancer. This study is part of a multistep process to develop practical guidelines in Germany. The purpose of this study was to identify instruments for the assessment of functioning using the ICF-HNC as reference. Methods Four Delphi surveys with physicians, physiotherapists, psychologists, and social workers were performed to identify which aspects of the ICF-HNC are being treated and which assessment tools are recommended for the assessment of functioning. Results Ninety-seven percent categorie…

AdultMalemedicine.medical_specialtyDelphi TechniqueHealth PersonnelDelphi methodInternational Classification of Functioning Disability and HealthInternational Classification of Functioning Disability and HealthHumansMedicineAgedcomputer.programming_languageSocial workbusiness.industryHead and neck cancerPerspective (graphical)Middle Agedmedicine.diseasePatient Outcome AssessmentOtorhinolaryngologyHead and Neck NeoplasmsPhysical therapyFemaleOutcomes researchbusinesshuman activitiescomputerPsychosocialDelphiHead & Neck
researchProduct

Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study

2007

In patients with relapsing-remitting multiple sclerosis (MS), IVIG was shown to reduce the relapse rate and progression of disability. In patients with chronic progressive MS, a beneficial effect of IVIG was not documented in placebo controlled studies. This trial investigated the influence of IVIG in primary (PPMS) and secondary (SPMS) chronic progressive MS. Two-hundred and thirty-one patients stratified for PPMS ( n = 34) and SPMS ( n = 197) were randomly assigned to IVIG 0.4 g/kg per month or to placebo for 24 months. Primary endpoints were 1) the time to sustained progression of disease identified as worsening of the expanded disability status scale (EDSS) sustained for 3 months, and …

AdultMalemedicine.medical_specialtyDiseasePlaceboPlacebosCentral nervous system diseaseDisability EvaluationDegenerative diseaseQuality of lifeRecurrencehemic and lymphatic diseasesInternal medicinemedicineHumansImmunologic FactorsProspective StudiesDepression (differential diagnoses)AgedExpanded Disability Status Scalebusiness.industryMultiple sclerosisImmunoglobulins IntravenousMiddle AgedMultiple Sclerosis Chronic Progressivemedicine.diseaseSurgeryTreatment OutcomeNeurologyDisease ProgressionFemaleNeurology (clinical)businessMultiple Sclerosis Journal
researchProduct

Changes in Health Utility, Disability, and Health-Related Quality of Life in Patients After Spinal Fusion

2014

STUDY DESIGN Prospective longitudinal database study. OBJECTIVE To evaluate changes in health utility, disability, and health-related quality of life (HRQOL) in patients undergoing spinal fusion. SUMMARY OF BACKGROUND DATA Recently, measuring disability, HRQOL, and health utility has become important when defining the value of surgical interventions. METHODS Data of spinal fusion patients from a prospective longitudinal database were analyzed. Health utility was captured by SF-6D (six dimensional health state classification from the 36-dimensional Short Form Health Survey) score, disability by Oswestry Disability Index, and HRQOL by the 36-Item Short Form Health Survey. The changes in these…

AdultMalemedicine.medical_specialtyHealth utilitySpinal stenosismedicine.medical_treatmentComorbidityPostoperative ComplicationsQuality of lifeHumansMedicineDisabled PersonsOrthopedics and Sports MedicineIn patientFinlandAgedHealth related quality of lifebusiness.industryta3141Evidence-based medicineMiddle Agedmedicine.diseaseOswestry Disability IndexSpinal FusionSpinal fusionQuality of LifePhysical therapyFemaleSpinal DiseasesNeurology (clinical)businessDelivery of Health CareSpine
researchProduct

Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclero…

2003

Summary Lower levels of N-acetylaspartate (NAA), a marker of axonal damage, have been found in the normal-appearing white matter (NAWM) of relapsing-remitting multiple sclerosis (RRMS) patients with low physical disability. However, its relation to the clinical status of these patients remains unclear. We explored the association between NAA levels [normalized to creatine (Cr), NAA/Cr] and a cognitive feature that is not measured by the standard scales that address functional disability [e.g. Expanded Disability Scale Score (EDSS)] in early RRMS. Given that a considerable number of RRMS patients present attentional dysfunction early in the disease and assuming a functional-anatomical orient…

AdultMalemedicine.medical_specialtyMagnetic Resonance SpectroscopyAudiologyLateralization of brain functionDichotic Listening TestsCentral nervous system diseaseWhite matterDisability EvaluationMultiple Sclerosis Relapsing-RemittingmedicineHumansAttentionAnalysis of VarianceAspartic AcidDichotic listeningMultiple sclerosismedicine.diseaseAxonsmedicine.anatomical_structurenervous systemLinear ModelsLocus coeruleusFemaleLocus CoeruleusNeurology (clinical)Analysis of varianceCognition DisordersPsychologyNeuroscienceReticular activating systemBiomarkersBrain
researchProduct

Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study.

2014

Objective: The objective of this paper is to identify clinical or magnetic resonance imaging (MRI) predictors of long-term clinical progression in a large cohort of multiple sclerosis (MS) patients. Methods: A total of 241 relapsing–remitting (RR) MS patients were included in a nine-year follow-up (FU) study. The reference MRIs were acquired at baseline (BL) as part of a multicenter, cross-sectional, clinical-MRI study. Volumetric MRI metrics were measured by a fully automated, operator-independent, multi-parametric segmentation method. Clinical progression was evaluated as defined by: conversion from RR to secondary progressive (SP) disease course; progression of Expanded Disability Status…

AdultMalemedicine.medical_specialtyMagnetic resonance imaging follow-up multiple sclerosis clinical predictors gray matter atrophypredictormultiple sclerosisDisease courseDisability EvaluationMultiple Sclerosis Relapsing-RemittingInternal medicinefollow-upmedicineHumansSecondary progressiveExpanded Disability Status Scalemedicine.diagnostic_testbusiness.industryMultiple sclerosisDisease progressionFollow up studiesMagnetic resonance imagingclinical predictorsMiddle Agedmedicine.diseaseMagnetic Resonance Imaginggray matter atrophyCross-Sectional StudiesNeurologymultiple sclerosiDisease ProgressionSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessNuclear medicineClinical progressionMRIFollow-Up StudiesMultiple sclerosis (Houndmills, Basingstoke, England)
researchProduct

Validity and reliability of the Migraine-Treatment Optimization Questionnaire.

2009

Our aim was to establish the validity and reliability of a patient-rated Migraine Treatment Optimization Questionnaire (M-TOQ in primary care. Patients who met International Classification of Headache Disorders, 2nd edn criteria for migraine completed a 19-item questionnaire containing candidate items for the M-TOQ and three questionnaires designed to test convergent/construct validity [Migraine Disability Assessment Scale (MIDAS), Headache Impact Test (HIT)-6 and Migraine-Specific Quality of Life Scale (MSSQoL)]. A 15-item (M-TOQ15) and a five-item (M-TOQ-5) questionnaire were derived. Two hundred and fifty-three adult patients were recruited. Five treatment optimization domains were iden…

AdultMalemedicine.medical_specialtyMigraine DisordersValidityDisability EvaluationQuality of lifeCronbach's alphaSurveys and QuestionnairesOutcome Assessment Health CareMedicineHumansMigraine treatmentAgedbusiness.industryConstruct validityReproducibility of ResultsGeneral MedicineMiddle Agedmedicine.diseaseTolerabilityMigrainePhysical therapyQuality of LifeInternational Classification of Headache DisordersFemaleNeurology (clinical)businessClinical psychologyCephalalgia : an international journal of headache
researchProduct

Multiple sclerosis severity score: Using disability and disease duration to rate disease severity

2005

Background: There is no consensus method for determining progression of disability in patients with multiple sclerosis (MS) when each patient has had only a single assessment in the course of the disease. Methods: Using data from two large longitudinal databases, the authors tested whether cross-sectional disability assessments are representative of disease severity as a whole. An algorithm, the Multiple Sclerosis Severity Score (MSSS), which relates scores on the Expanded Disability Status Scale (EDSS) to the distribution of disability in patients with comparable disease durations, was devised and then applied to a collection of 9,892 patients from 11 countries to create the Global MSSS. I…

AdultMalemedicine.medical_specialtyMultiple SclerosisDatabases FactualCross-sectional studyModels NeurologicalDiseaseSUSCEPTIBILITYSeverity of Illness IndexCohort StudiesDisability EvaluationPredictive Value of TestsRecurrenceSeverity of illnessmedicineHumansLongitudinal StudiesAge of OnsetModels StatisticalExpanded Disability Status Scalebusiness.industryMultiple sclerosisOUTCOME MEASUREReproducibility of ResultsNATURAL-HISTORYMiddle AgedPrognosismedicine.diseaseCross-Sectional StudiesPredictive value of testsDisease ProgressionPhysical therapyFemaleFranceNeurology (clinical)Age of onsetbusinessCohort study
researchProduct

Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple Sclerosis

2020

ObjectiveTo examine acute (single-bout) and training effects of high-intensity interval training (HIIT) vs standard exercise therapy (moderate continuous training [MCT]) on plasma neurofilament light chain (pNfL) and kynurenine (KYN) pathway of tryptophan degradation metabolites in persons with multiple sclerosis (pwMS).MethodsSixty-nine pwMS (Expanded Disability Status Scale score 3.0–6.0) were randomly assigned to a HIIT or an MCT group. Changes in pNfL and KYN pathway metabolites measured in blood plasma were assessed before, after, and 3 hours after the first training session as well as after the 3-week training intervention.ResultsAcute exercise reduced pNfL and increased the KYN pathw…

AdultMalemedicine.medical_specialtyMultiple SclerosisKynurenine pathway41132NeuroprotectionArticleInterval trainingchemistry.chemical_compoundKynurenic acidNeurofilament ProteinsInternal medicineBlood plasmamedicineHumansSingle-Blind MethodProspective StudiesExerciseKynurenineAgedAged 80 and overExpanded Disability Status Scalebusiness.industryMultiple sclerosisTryptophanMiddle Agedmedicine.diseaseExercise TherapyEndocrinologyNeurologychemistryFemaleNeurology (clinical)businessKynurenineNeurology - Neuroimmunology Neuroinflammation
researchProduct

EDSS correlated analysis of median nerve somatosensory evoked potentials in multiple sclerosis

2001

Median nerve somatosensory evoked potentials (SEP) were recorded in 30 patients with multiple sclerosis. The examined patients had an expanded disability status scale (EDSS) between 0 and 6. The primary cortical potential N20, the subcortical potentials P14, N13b, N13a and the peripheral potential P9 were recorded simultaneously. In 5 patients normal SEP were observed (group 1), and in 6 patients there were consecutive disturbances of the somatosensory pathway (group 3). In 19 patients subcortical potentials were abnormal or absent while the following potentials were normal or identified which pattern corresponds to amplification within CNS structures (group 2). The EDSS of groups 1 and 2 w…

AdultMalemedicine.medical_specialtyMultiple SclerosisNeurologyNeural ConductionDermatologyAudiologyEvoked Potentials SomatosensoryInternal medicinemedicineHumansAgedNeuroradiologyExpanded Disability Status ScaleMultiple sclerosisBrainGeneral MedicineMiddle Agedmedicine.diseaseMedian nerveMedian NervePeripheralPsychiatry and Mental healthSomatosensory evoked potentialCardiologyFemaleNeurology (clinical)NeurosurgeryPsychologyNeurological Sciences
researchProduct

Electrophysiological patterns of oropharyngeal swallowing in multiple sclerosis.

2012

Abstract Objective We performed an electrophysiological study of swallowing (EPSS) in multiple sclerosis (MS) to describe oropharyngeal swallowing abnormalities and to analyze their correlations with dysphagia and with overall neurological impairment. Methods Neurological examinations were quantified using the Kurtzke Functional Systems and the Expanded Disability Status Scale (EDSS). Dysphagia was evaluated using the Dysphagia in Multiple Sclerosis (DYMUS) questionnaire, while fiberoptic endoscopic evaluation of swallowing (FEES) was used to establish the degree of aspiration and penetration, graded using the penetration–aspiration scale (PAS). The EPSS measured the duration of suprahyoid/…

AdultMalemedicine.medical_specialtyMultiple SclerosisOropharynxElectromyographyBladder Sphincter DysfunctionDysphagia swallowing electromiography multiple sclerosisSwallowingPhysiology (medical)otorhinolaryngologic diseasesmedicineHumansAgedExpanded Disability Status Scalemedicine.diagnostic_testbusiness.industryElectromyographyMultiple sclerosisMiddle Agedmedicine.diseaseDysphagiaSensory SystemsPathophysiologySurgeryDeglutitionNeurologyAnesthesiaFemaleNeurology (clinical)medicine.symptomAbnormalitybusinessDeglutition DisordersClinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
researchProduct